- Home
- CCTG vs INAB Comparison
CCTG vs INAB Comparison
Compare CCTG & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- INAB
- Stock Information
- Founded
- CCTG 1993
- INAB 2016
- Country
- CCTG Hong Kong
- INAB United States
- Employees
- CCTG N/A
- INAB N/A
- Industry
- CCTG
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- CCTG
- INAB Health Care
- Exchange
- CCTG Nasdaq
- INAB Nasdaq
- Market Cap
- CCTG 18.9M
- INAB 18.8M
- IPO Year
- CCTG 2024
- INAB 2021
- Fundamental
- Price
- CCTG $1.52
- INAB $0.17
- Analyst Decision
- CCTG
- INAB Strong Buy
- Analyst Count
- CCTG 0
- INAB 2
- Target Price
- CCTG N/A
- INAB $3.60
- AVG Volume (30 Days)
- CCTG 40.6K
- INAB 1.1M
- Earning Date
- CCTG 12-27-2024
- INAB 03-13-2025
- Dividend Yield
- CCTG N/A
- INAB N/A
- EPS Growth
- CCTG N/A
- INAB N/A
- EPS
- CCTG N/A
- INAB N/A
- Revenue
- CCTG $16,463,490.00
- INAB N/A
- Revenue This Year
- CCTG N/A
- INAB N/A
- Revenue Next Year
- CCTG N/A
- INAB N/A
- P/E Ratio
- CCTG N/A
- INAB N/A
- Revenue Growth
- CCTG 3.27
- INAB N/A
- 52 Week Low
- CCTG $1.20
- INAB $0.16
- 52 Week High
- CCTG $3.41
- INAB $1.74
- Technical
- Relative Strength Index (RSI)
- CCTG 40.16
- INAB 27.23
- Support Level
- CCTG $1.50
- INAB $0.16
- Resistance Level
- CCTG $1.79
- INAB $0.25
- Average True Range (ATR)
- CCTG 0.16
- INAB 0.02
- MACD
- CCTG -0.01
- INAB -0.01
- Stochastic Oscillator
- CCTG 4.26
- INAB 9.77
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.